Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa

NCT00987142 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

EPIDERMOLYSIS BULLOSA

Interventions

DRUG: CX501
DEVICE: Occlusive non adherent dressing

Sponsor

Tigenix S.A.U.